West Virginia University
Effects of Aripiprazole Alone and in Combination with d-Amphetamine on Probability Discounting in Sprague-Dawley Rats
Abstract
dc:description.abstractPharmaceuticals are helpful tools in aiding individuals with psychiatric diagnoses. Sometimes, the drug’s side effects can be more severe than the initial problem. Maladaptive behaviors, like pathological gambling, overeating, and substance abuse, are important to consider during the prescription of different pharmaceuticals, particularly those used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and autism spectrum disorder (ASD). Individuals with these diagnoses are often prescribed: stimulants, like d-amphetamine (d-AMP; for symptoms associated with ADHD), and antipsychotics, like aripiprazole (ARI; for symptoms associated with ASD). These drugs in combination could influence maladaptive behavior, including risky choice (probability discounting). The present study used eight, male Sprague-Dawley rats to examine effects of ARI, alone and in combination with d-AMP, on risky choice. Results demonstrate an interaction between the two drugs, indicated by an increase in risky choice over and above what either drug does alone. Drug combinations in behavioral research are understudied, hence it is imperative that we develop a better understanding of how drug combinations influence choice.
Degree
thesis:*- Name thesis:degree_name
- MS
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Psychology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Currie, Paige
- Contributors dc:contributor
-
- Karen Anderson
- Michael Perone
- Christina Duncan
Subjects
dc:subject × 6Identifiers
dc:identifier.*- Identifier
-
<p><a href="https://orcid.org/0000-0002-7655-8188">https://orcid.org/0000-0002-7655-8188</a></p>
https://researchrepository.wvu.edu/etd/11889